INS and type 2 diabetes mellitus: A potential limitation of our findings is that this was an exploratory pilot study to evaluate the protective effects on the β cell by initiating basal insulin therapy with metformin in individuals with type 2 diabetes, pretreated with OADs (sulfonylurea in combination with metformin).